Market Research Logo

AcelRx Pharmaceuticals Inc (ACRX) - Financial and Strategic SWOT Analysis Review

AcelRx Pharmaceuticals Inc (ACRX) - Financial and Strategic SWOT Analysis Review

- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

AcelRx Pharmaceuticals Inc (AcelRx), is a specialty pharmaceutical company that develops and commercializes novel therapies for the treatment of pain. The company’s lead product candidate, DSUVIA (known as ARX-04 outside the US), is a single sufentanil sublingual tablet for the treatment of moderate-to-severe acute pain. It pipeline also includes ZALVISO, a drug and device combination product for management of moderate to severe acute pain in adults. AcelRx incorporates non-invasive, sublingual formulation technology to deliver highly drugs of its product candidates. The company commercializes ZALVISO under license agreement with Grunenthal in the European Union countries, Switzerland, Liechtenstein, Iceland, Norway, and Australia. AcelRx is headquartered in Redwood City, California, the US.

AcelRx Pharmaceuticals Inc Key Recent Developments

May 08,2017: AcelRx Pharmaceuticals Reports First Quarter 2017 Financial Results and Provides Corporate Update
Mar 02,2017: AcelRx Pharmaceuticals Reports Fourth Quarter and Year End 2016 Financial Results
Feb 16,2017: AcelRx Pharmaceuticals Appoints Vincent J. Angotti Chief Executive Officer
Nov 01,2016: AcelRx Pharmaceuticals Provides Corporate Update and Reports Third Quarter and Nine Months 2016 Financial Results
Jul 28,2016: AcelRx Pharmaceuticals Provides Corporate Update and Reports Second Quarter and Six Months 2016 Financial Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company 6
AcelRx Pharmaceuticals Inc - Key Facts 6
AcelRx Pharmaceuticals Inc - Key Employees 7
AcelRx Pharmaceuticals Inc - Major Products and Services 8
AcelRx Pharmaceuticals Inc - History 9
AcelRx Pharmaceuticals Inc - Company Statement 10
AcelRx Pharmaceuticals Inc - Locations And Subsidiaries 14
Head Office 14
Other Locations & Subsidiaries 14
Section 2 – Company Analysis 15
AcelRx Pharmaceuticals Inc - Business Description 15
AcelRx Pharmaceuticals Inc - Corporate Strategy 16
AcelRx Pharmaceuticals Inc - SWOT Analysis 17
SWOT Analysis - Overview 17
AcelRx Pharmaceuticals Inc - Strengths 17
AcelRx Pharmaceuticals Inc - Weaknesses 18
AcelRx Pharmaceuticals Inc - Opportunities 19
AcelRx Pharmaceuticals Inc - Threats 20
AcelRx Pharmaceuticals Inc - Key Competitors 21
Section 3 – Company Financial Ratios 22
Financial Ratios - Capital Market Ratios 22
Financial Ratios - Annual Ratios 23
Performance Chart 25
Financial Performance 25
Financial Ratios - Interim Ratios 26
Financial Ratios - Ratio Charts 27
Section 4 – Company’s Lifesciences Financial Deals and Alliances 28
AcelRx Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 28
AcelRx Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 29
AcelRx Pharmaceuticals Inc, Recent Deals Summary 30
Section 5 – Company’s Recent Developments 31
May 08, 2017: AcelRx Pharmaceuticals Reports First Quarter 2017 Financial Results and Provides Corporate Update 31
Mar 02, 2017: AcelRx Pharmaceuticals Reports Fourth Quarter and Year End 2016 Financial Results 33
Feb 16, 2017: AcelRx Pharmaceuticals Appoints Vincent J. Angotti Chief Executive Officer 35
Nov 01, 2016: AcelRx Pharmaceuticals Provides Corporate Update and Reports Third Quarter and Nine Months 2016 Financial Results 36
Jul 28, 2016: AcelRx Pharmaceuticals Provides Corporate Update and Reports Second Quarter and Six Months 2016 Financial Results 38
May 02, 2016: AcelRx Pharmaceuticals Provides Corporate Update and Reports First Quarter 2016 Financial Results 41
Mar 29, 2016: AcelRx Pharmaceuticals Names Howard B. Rosen as Chief Executive Officer and Provides Update on Clinical Development Activities and Corporate Priorities for 2016 43
Mar 07, 2016: AcelRx Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full Year 2015 Financial Results 44
Section 6 – Appendix 46
Methodology 46
Ratio Definitions 46
About GlobalData 50
Contact Us 50
Disclaimer 50
List of Tables
AcelRx Pharmaceuticals Inc, Key Facts 6
AcelRx Pharmaceuticals Inc, Key Employees 7
AcelRx Pharmaceuticals Inc, Major Products and Services 8
AcelRx Pharmaceuticals Inc, History 9
AcelRx Pharmaceuticals Inc, Subsidiaries 14
AcelRx Pharmaceuticals Inc, Key Competitors 21
AcelRx Pharmaceuticals Inc, Ratios based on current share price 22
AcelRx Pharmaceuticals Inc, Annual Ratios 23
AcelRx Pharmaceuticals Inc, Annual Ratios (Cont...1) 24
AcelRx Pharmaceuticals Inc, Interim Ratios 26
AcelRx Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 28
AcelRx Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 29
AcelRx Pharmaceuticals Inc, Recent Deals Summary 30
Currency Codes 46
Capital Market Ratios 46
Equity Ratios 47
Profitability Ratios 47
Cost Ratios 48
Liquidity Ratios 48
Leverage Ratios 49
Efficiency Ratios 49
List of Figuress
AcelRx Pharmaceuticals Inc, Performance Chart (2012 - 2016)
AcelRx Pharmaceuticals Inc, Ratio Charts
AcelRx Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
AcelRx Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report